money.cnn.com

money.cnn.com
Share

money.cnn.com

 •  February 16

Food and Drug Administration Commissioner Scott Gottlieb said he will do everything "within my lane" to combat high drug prices and that he sees drug companies "gaming the system to try to block competition" in a multitude of ways in the marketplace. In an interview with Kaiser Health News on Thursday, Gottlieb also said that he wants to speed up...

money.cnn.com

 •  February 15

An Irish drugmaker has jacked up the price of a painkiller to nearly $3,000 a bottle. The drug is 22 times more expensive than when the company acquired it in late 2013. The sticker shock for Horizon Pharma's Vimovo drug is magnified by the fact that the painkiller's two main ingredients can be purchased separately -- for just $36. Although...

money.cnn.com

 •  February 14

Warren Buffett is making another big bet on health care. His company Berkshire Hathaway (BRKA) recently took a $358 million stake in Teva Pharmaceutical (TEVA), an Israeli company that makes generic drugs. It fills about one in six generic prescriptions in the United States. The company's stock spiked about 7% after the market closed. Buffett's...

money.cnn.com

 •  February 12

President Donald Trump finally explained how he plans to fulfill his promise of lowering prescription drug prices -- at least in part. On Monday, his administration released its 2019 budget blueprint, which proposed changes to payment policies in Medicare and Medicaid and fast-tracking the development of generic drugs as ways to help accomplish...

money.cnn.com

 •  February 14, 2017

In one of the biggest corporate deals ever, Pfizer and Allergan announced Monday that they would combine to create the world's largest pharmaceutical giant. The merger, which still needs regulatory approval, would bring blockbuster drugs like Pfizer's Lyrica, Enbrel and Viagra and Allergan's Botox and Restasis under one corporate roof. Consumers...

money.cnn.com

 •  February 14, 2017

Scientists at Oxford University have launched the first clinical trial of a new Ebola vaccine. The first of 72 healthy volunteers have already received the initial dose of a drug researchers hope could put an end to the worst Ebola outbreak in the history. Janssen Pharmaceutical Companies, owned by Johnson & Johnson (JNJ), is developing the vaccine...

money.cnn.com

 •  February 14, 2017

Remember the drug used by cancer and AIDS patients that skyrocketed from $13.50 to $750 a pill? Well, the price has yet to come back to earth. The company still has not cut the price below $750 even though it vowed that it would on national TV and in a public statement over two weeks ago. "We've agreed to lower the price of Daraprim to a price that...